Syed Zafar
Overview:
Dr. Zafar is a gastrointestinal medical oncologist and Associate Professor of Medicine, Public Policy, and Population Health Science at the Duke Cancer Institute and Duke-Margolis Center for Health Policy. He serves as Director of Healthcare Innovation at the Duke Cancer Institute. Dr. Zafar also serves as Clinical Associate Director of Duke Forge (Health Data Science Center). Dr. Zafar is considered an international expert in identifying and intervening upon the financial burden of cancer care. His research explores ways to improve cancer care delivery with a primary focus on improving the value of cancer treatment from both patient-focused and policy perspectives.
Dr. Zafar speaks internationally on his research and cancer care delivery. He has over 100 publications in top peer-reviewed journals including the New England Journal of Medicine, the Journal of Clinical Oncology, and JAMA Oncology. His research has been funded by the National Institutes of Health and the American Cancer Society, among others. His work has been covered by national media outlets including New York Times, Forbes, Wall Street Journal, NPR, and Washington Post. He is a Fellow of the American Society of Clinical Oncology.
Positions:
Associate Professor of Medicine
Associate Professor in the Sanford School of Public Policy
Associate Professor in Population Health Sciences
Affiliate, Duke Global Health Institute
Core Faculty Member, Duke-Margolis Center for Health Policy
Member of the Duke Cancer Institute
Member in the Duke Clinical Research Institute
Education:
M.D. 2002
Resident, Medicine
Fellow in Hematology-Oncology, Medicine
Grants:
Couple Communication in Cancer: A Multi-method Examination
Examining Best Practices for Factoring Out-Of-Pocket Expenses into Patients' Health Care Decisions
Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training
PAPNavigator STTR (Fast-Track)
Using AACT - to answer Oncology landscape portfolio of open trials
Publications:
Reply to S. Boutayeb et al.
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions.
Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed
THE RELATIONSHIP INTIMACY MODEL OF COUPLE ADAPTATION TO CANCER: SUPPORT FROM A PROSPECTIVE, LONGITUDINAL, SMARTPHONE-ENABLED ECOLOGICAL MOMENTARY ASSESSMENT STUDY
Research Areas:
